Tilray | TRLY - 资产

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.55B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	资产	更改		日
Acasti Pharma	USD 66.58M		3.22M	2025-09
Akebia Therapeutics	USD 362.52M		14.04M	2026-03
Alaunos Therapeutics	USD 1.88M		1.08M	2026-03
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Avita Medical	AUD 56.39M		1.74M	2025-12
Canopy Growth	CAD 1.11B		36.35M	2025-12
Cronos Group	USD 1.17B		25.03M	2026-03
Dianthus Therapeutics	USD 1.25B		715.96M	2026-03
Divis Laboratories Ltd	INR 200.33B		18.82B	2026-03
Ionis Pharmaceuticals	USD 3.45B		74M	2026-03
IQVIA Holdings	USD 29.68B		269M	2026-03
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Moderna	USD 11.49B		850M	2026-03
Organigram Holdings	CAD 530.67M		31.54M	2025-12
Organon & Co	USD 13B		129M	2026-03
Revvity	USD 12B		171.82M	2026-03
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
Tilray	USD 2.1B		15.95M	2025-09
Viatris	USD 36.83B		358.5M	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03
Zealand Pharma A/S	15.95B		848.45M	2025-12